• By Lauren Csukardi
  • Posted August 26, 2025

From Research to Reclass: 4,200+ Patients Impacted...and Counting!

In line with our commitment to lead through expert science, we’re proactively reclassifying BRCA2 variants—bringing clarity to patients facing uncertainty and empowering informed health decisions. From Research... Ambry proudly collaborated on the groundbreaking Nature study, Functional Evaluation and Clinical Classification of…